PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE anti-human XCR1, 25 tests
PE anti-human β2-microglobulin, 100 tests
PE anti-human β2-microglobulin, 25 tests
PE anti-human/mouse Bcl-6, 100 tests
PE anti-human/mouse Bcl-6, 25 tests
PE anti-human/mouse CD266 (Fn14, TWEAK Receptor), 100 μg
PE anti-human/mouse CD3ε (activation epitope), 100 tests
PE anti-human/mouse CD3ε (activation epitope), 25 tests
PE anti-human/mouse CD49f, 100 tests
PE anti-human/mouse CD49f, 25 tests
PE anti-human/mouse Cutaneous Lymphocyte Antigen (CLA), 100 tests
PE anti-human/mouse Cutaneous Lymphocyte Antigen (CLA), 25 tests
PE anti-human/mouse CXCR7, 100 tests
PE anti-human/mouse CXCR7, 25 tests
PE anti-human/mouse Granzyme B Recombinant, 100 tests
PE anti-human/mouse Granzyme B Recombinant, 25 tests